One hundred and nine strains of Haemophilus influenzae recovered from clinical specimens were examined for antibiotic sensitivity pattern and capsular types. All strains from blood cultures, cerebrospinal fluid and a joint aspirate were type b whereas most of the isolates were acapsular when recovered from other specimens viz. wound secretions (67%), maxillary sinus (75%), lower resp tract (86%), nasal cavity (90%). Out of the 109 strains 88 (81%) were non‐typable, and 3,6% were beta‐lactamase‐producing, two of which were type e, one was type b and one was acapsular. Three beta‐lactamase‐producing strains were isolated from specimens from the respiratory tract and one from blood cultures. Beta‐lactamase‐producing strains including one chloramphenicol‐resistant strain harboured similar plasmids, as judged by agarose gel electrophoresis. The strains showed quite a uniform sensitivity to antibacterial agents with the exception of sulphonamides to which the capsular strains, particularly type b strains, were less susceptible.
34 penicillinase-producing (PPNG) and 102 nonpenicillinase producing (non-PPNG) strains of Neisseria gonorrhoeae were tested against 9 antibacterial agents. Cefoxitin, latamoxef, cefotaxime and imipenem inhibited all PPNG (MIC < 2 mg/l); chloramphenicol (2 mg/l) inhibited 86%, and 3% and 8%, respectively, were inhibited by 1 mg/1 of doxycycline when disk diffusion or agar dilution sensitivity testing were performed. All PPNG strains were sensitive to spectinomycin (MIC < 32 mg/l). Non-PPNG strains were uniformly sensitive to all antibacterial agents, doxycycline being slightly less active than the other compounds.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.